No attachments available.
On September 11, 2017, Medical Readiness awarded a Pharmaceutical contract to Alvogen, Inc. for fourteen (14) product lines
Contact and place of performance
Sunday O. Oladele
Not specified
On September 11, 2017, DLA Troop Support awarded a new contract SPE2D0-17-D-0008 to Alvogen Inc under Open Season Solicitation SPE2D0-15-R-0002. This is an Indefinite Delivery-Indefinite Quantity (IDIQ) fixed price type contract with Economic Price Adjustment (EPA) clauses for various Pharmaceutical products in support of the Corporate Exigency Contracts (CEC) program. The contract is for ten years (one-year base, wi...
View moreDLA Troop Support awarded a fixed-price Indefinite Delivery-Indefinite Quantity (IDIQ) contract to Alvogen, Inc. on September 11, 2017. This award, designated as contract number SPE2D0-17-D-0008, was issued under Open Season Solicitation SPE2D015R0002. The agreement includes Economic Price Adjustment clauses and covers fourteen pharmaceutical product lines. The contract structure consists of a one-year base period with options to extend for nine additional one-year terms, totaling a potential ten-year performance period.
The contract supports the Corporate Exigency Contracts (CEC) program, which establishes partnerships between the Department of Defense and private industry to maintain readiness for increased demand during mobilization, war, or military contingencies. This specific acquisition purchases access to critical pharmaceutical items to ensure the industrial base can support military service requirements. The primary point of contact for this award is Sunday O. Oladele.
This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC code 65. There were no attachments included with the award notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.